Patents by Inventor David Ernst

David Ernst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11949811
    Abstract: An example method is described. The method includes receiving, by a computing system, data indicative of a call into an interactive voice response (IVR) system from a user device and determining, by the computing system and based on the data, a set of actions performed by the user device within the IVR system and a corresponding set of results performed by the IVR system during the call. Additionally, the method includes converting, by the computing system, the set of actions and the corresponding set of results into a sequence of code pairs using a dictionary established based on training data, determining, by the computing system, an activity pattern during the call based on the sequence of code pairs; and calculating, by the computing system, a probability that the call is fraudulent based on the activity pattern during the call.
    Type: Grant
    Filed: October 17, 2022
    Date of Patent: April 2, 2024
    Assignee: Wells Fargo Bank, N.A.
    Inventors: Nick A. Maiorana, Judy Cantor, Kevin R. Cieslak, David Gorlesky, Jeremy Ernst
  • Publication number: 20240100183
    Abstract: Composition and methods to prevent, inhibit or treat one or more symptoms of cystic fibrosis are provided.
    Type: Application
    Filed: December 10, 2021
    Publication date: March 28, 2024
    Inventors: Aliasger K. Salem, David A. Stoltz, Michael J. Welsh, Sarah Ernst, Youssef W. Naguib, David S. NAkhla, Aml I. Mekkawy, Nikesh Gupta
  • Publication number: 20240084322
    Abstract: The present disclosure relates to cells, tissues, organs, and/or animals having one or more modified genes for enhanced xenograft survival and/or tolerance. In addition, the present disclosure relates to methods of making and using the cells, tissues, organs, and/or animals having one or more of the modified genes.
    Type: Application
    Filed: June 1, 2023
    Publication date: March 14, 2024
    Inventors: Jacob LAYER, Wenning QIN, Yinan KAN, Juliet CRABTREE, Michele YOUD, David HEJA, David ANGELES ALBORES, Ranjith ANAND, Paola PERRAT, Russell ERNST, Violette PARAGAS
  • Patent number: 11808831
    Abstract: The magnetic resonance member 1 is a member that is arranged in a measurement target AC physical field, and in which a quantum operation can be performed in a specific quantum system. The coil 2 and the high frequency power supply 3 apply a magnetic field of a microwave to the magnetic resonance member 1. The irradiating device 4 irradiates the magnetic resonance member 1 with light, and the detecting device 5 detects from the magnetic resonance member 1 a physical phenomenon corresponding to the measurement target AC physical field. Further, the measurement control unit 21 performs the DC physical field measurement sequence a predetermined plural times, and in each of the plural times of the DC physical field measurement sequence, determines a detection value of the physical phenomenon detected by the detecting device 5.
    Type: Grant
    Filed: December 17, 2020
    Date of Patent: November 7, 2023
    Inventors: David Ernst Herbschleb, Norikazu Mizuochi, Yoshiharu Yoshii
  • Publication number: 20220373628
    Abstract: The magnetic resonance member 1 is a member that is arranged in a measurement target AC physical field, and in which a quantum operation can be performed in a specific quantum system. The coil 2 and the high frequency power supply 3 apply a magnetic field of a microwave to the magnetic resonance member 1. The irradiating device 4 irradiates the magnetic resonance member 1 with light, and the detecting device 5 detects from the magnetic resonance member 1 a physical phenomenon corresponding to the measurement target AC physical field. Further, the measurement control unit 21 performs the DC physical field measurement sequence a predetermined plural times, and in each of the plural times of the DC physical field measurement sequence, determines a detection value of the physical phenomenon detected by the detecting device 5.
    Type: Application
    Filed: December 17, 2020
    Publication date: November 24, 2022
    Inventors: David Ernst HERBSCHLEB, Norikazu MIZUOCHI, Yoshiharu YOSHII
  • Patent number: 10104409
    Abstract: Apparatus and methods for segmenting television audience data are disclosed. The methods include receiving program level viewing data for one or more individuals. The methods also include creating one or more segments for the one or more individuals based upon the program level viewing data. The methods further include combining the one or more segments into one or more groups by applying a grouping function and performing analysis on the one or more groups, and generating reports based upon the analysis.
    Type: Grant
    Filed: June 30, 2017
    Date of Patent: October 16, 2018
    Assignee: DISCOVERY COMMUNICATIONS, LLC
    Inventors: Elizabeth Rockwood Fulton, David Ernst, Steve Ozzano
  • Publication number: 20170302980
    Abstract: Apparatus and methods for segmenting television audience data are disclosed. The methods include receiving program level viewing data for one or more individuals. The methods also include creating one or more segments for the one or more individuals based upon the program level viewing data. The methods further include combining the one or more segments into one or more groups by applying a grouping function and performing analysis on the one or more groups, and generating reports based upon the analysis.
    Type: Application
    Filed: June 30, 2017
    Publication date: October 19, 2017
    Applicant: Discovery Communications, LLC
    Inventors: Elizabeth Rockwood FULTON, David ERNST, Steve OZZANO
  • Patent number: 9729908
    Abstract: Apparatus and methods for segmenting television audience data are disclosed. The methods include receiving program level viewing data for one or more individuals. The methods also include creating one or more segments for the one or more individuals based upon the program level viewing data. The methods further include combining the one or more segments into one or more groups by applying a grouping function and performing analysis on the one or more groups, and generating reports based upon the analysis.
    Type: Grant
    Filed: August 25, 2015
    Date of Patent: August 8, 2017
    Assignee: Discovery Communications, LLC
    Inventors: Elizabeth Rockwood Fulton, David Ernst, Steve Ozzano
  • Patent number: 9148680
    Abstract: Apparatus and methods for segmenting television audience data are disclosed. The methods include receiving program level viewing data for one or more individuals. The methods also include creating one or more segments for the one or more individuals based upon the program level viewing data. The methods further include combining the one or more segments into one or more groups by applying a grouping function and performing analysis on the one or more groups, and generating reports based upon the analysis.
    Type: Grant
    Filed: July 8, 2011
    Date of Patent: September 29, 2015
    Assignee: Discovery Communications, LLC
    Inventors: Elizabeth Rockwood Fulton, David Ernst, Steve Ozzano
  • Publication number: 20080107750
    Abstract: Described are packaged, sterile medical graft products containing controlled levels of a growth factor such as Fibroblast Growth Factor-2 (FGF-2). Also described are methods of manufacturing medical graft products wherein processing, including sterilization, is controlled and monitored to provide medical graft products having modulated, known levels of a extracellular matrix factor, such as a growth factor, e.g. FGF-2. Preferred graft materials are extracellular matrix materials isolated from human or animal donors, particularly submucosa-containing extracellular matrix materials. Further described are ECM compositions that are or are useful for preparing gels, and related methods for preparation and use.
    Type: Application
    Filed: September 7, 2007
    Publication date: May 8, 2008
    Inventors: Jason Hodde, David Ernst, Lal Ninan, Sherry Voytik-Harbin, Nathan Hammond
  • Publication number: 20070122390
    Abstract: Described are devices, methods, and systems for grafting tissues or organs that are exposed to bacterial or mammalian enzymes that degrade collagenous materials. Illustrative medical grafts are processed by contacting a collagenous extracellular matrix (ECM) material with a mono-carboxylic acid having from four to about twelve carbon atoms, or mixtures of two or more such acids.
    Type: Application
    Filed: January 30, 2007
    Publication date: May 31, 2007
    Inventors: Jason Hodde, David Ernst
  • Publication number: 20070100363
    Abstract: A system for making a precise incision and circular hole in a vessel wall, such as the aorta, that eliminates lateral side notches from the aortotomy. In one aspect, the system includes a surgical knife or lancet having a blade surrounded by a retractable shield. In one aspect, the system includes a tissue punch having a rotating circumferential edge for receiving a parabolic-shaped anvil having an anvil cutting edge. The anvil is placed through an incision made by a knife and actuated to produce a hole in the vessel wall.
    Type: Application
    Filed: October 27, 2005
    Publication date: May 3, 2007
    Inventors: Michael Dollar, Victor Dubuclet, David Ernst
  • Publication number: 20070082060
    Abstract: Described are packaged, sterile medical graft products containing controlled levels of a growth factor such as Fibrob-last Growth Factor-2 (FGF-2). Also described are methods of manufacturing medical graft products wherein processing, including sterilization, is controlled and monitored to provide medical graft products having modulated, known levels of a extracellular matrix factor, such as a growth factor, e.g. FGF-2. Preferred graft materials are extracellular matrix materials isolated from human or animal donors, particularly submucosa containing extracellular matrix materials. Further described are ECM compositions that are or are useful for preparing gels, and related methods for preparation and use.
    Type: Application
    Filed: August 25, 2004
    Publication date: April 12, 2007
    Inventors: Michael Hiles, Jason Hodde, David Ernst, Lal Ninan
  • Patent number: 6894796
    Abstract: Disclosed is a method, system, and logic for processing pixel data. A first and second logic units each receive line work data and control data for pixels on a sheet from at least one object. The control data for one pixel indicates whether to use the line work data for the pixel or contone data for the pixel. Multiple objects may provide line work data and control data for a same pixel. The first and second logic units output control data indicating to use contone data or line work data for the pixel. A third logic unit receives the line work and control data outputted from the first and second logic units. The third logic unit then outputs control data indicating to use the contone data or line work data for the pixel.
    Type: Grant
    Filed: May 12, 2000
    Date of Patent: May 17, 2005
    Assignee: International Business Machines Corporation
    Inventors: David Ernst Finlay, Phillip Keith Hoskins
  • Patent number: D1025419
    Type: Grant
    Filed: May 27, 2022
    Date of Patent: April 30, 2024
    Assignee: Coast Cutlery Co.
    Inventors: Todd Ernst, Douglas R. Hutchens, David D. Lewin, Wangda Rong, Zhongqiu Xu
  • Patent number: D1026266
    Type: Grant
    Filed: May 27, 2022
    Date of Patent: May 7, 2024
    Assignee: Coast Cutlery Co.
    Inventors: Todd Ernst, Douglas R. Hutchens, David D. Lewin, Wangda Rong, Zhongqiu Xu